Validity of the French Version of the Child's Chronic Rhinosinusitis Questionnaire
SN5-FR
2 other identifiers
observational
89
1 country
1
Brief Summary
A single quality questionnaire evaluating the symptoms of chronic rhinosinusitis in children currently exists. It has been validated in English for children aged 2 to 12. It comprises five areas of quality of life, each rated by a score ranging from 1 to 7 : sinus infection, nasal obstruction, allergic symptoms, emotional distress and activity limitation, coupled with an overall assessment of quality of life with an analogue visual scale (score from 1 to 10). This SN-5 (sinus and nasal quality of life survey) score showed excellent statistics of reproducibility, internal validity and ease of response. It is currently used in several international publications evaluating chronic sinus pathology in children. The objective of the study is to validate the translation of the SN-5 questionnaire in French.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2019
CompletedFirst Posted
Study publicly available on registry
October 7, 2019
CompletedStudy Start
First participant enrolled
April 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 11, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 11, 2020
CompletedMarch 11, 2026
March 1, 2026
2 months
October 3, 2019
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Reproducibility
Reproducibility of the questionnaire completed by a subject at 15 days apart. Student t-test.
1 year
Consistency reliability test
Measure of efficiency. Comparison of questionnaires completed by patients and controls.
1 year
Item-total Pearson correlation
Measure of efficiency. Comparison of questionnaires completed by patients and controls.
1 year
Principal components analysis
Measure of efficiency. Comparison of questionnaires completed by patients and controls.
1 year
Study Arms (2)
Patients
Patients of 2 and 12 years of age with chronic rhinosinusitis.
Controls
Subjects of 2 and 12 years of age without chronic rhinosinusitis.
Interventions
Subjects respond to the translated questionnaire twice at 15 days apart.
Eligibility Criteria
Patients followed by the department of otolaryngology and cervico-facial surgery of Necker-Enfants Malades hospital and siblings for the control subjects.
You may qualify if:
- Non-opposition of the holders of parental authority and the subject to participation in the study
- Subjects between 2 and 12 years of age Patients : - Patients followed in consultation at Necker Hospital in pediatric department of otolaryngology and cervico-facial surgery for chronic rhinosinusitis (rhinosinusitis more than 12 weeks)
- Controls :
You may not qualify if:
- French language not spoken by parents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AP-HP, Hôpital Necker-Enfants Malades
Paris, 75015, France
Related Publications (1)
Gargula S, Luscan R, Drummond D, Denoyelle F, Couloigner V, Leboulanger N, Simon F. French translation and validation of the Sinus and Nasal Quality of Life Survey (SN-5) in children. Int J Pediatr Otorhinolaryngol. 2021 Jun;145:110706. doi: 10.1016/j.ijporl.2021.110706. Epub 2021 Apr 6.
PMID: 33862327RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas Leboulanger, MD PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2019
First Posted
October 7, 2019
Study Start
April 6, 2020
Primary Completion
June 11, 2020
Study Completion
June 11, 2020
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share